Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 2
4(100.0%)
4Total
Phase 2(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05063201Phase 2Completed

Cariprazine for Comorbid Cocaine and Opioid Use Disorder

Role: lead

NCT00142818Phase 2Completed

Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence

Role: lead

NCT00167245Phase 2Completed

Topiramate for Alcohol and Cocaine Dependence

Role: lead

NCT00368290Phase 2Completed

Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior

Role: lead

All 4 trials loaded